Literature DB >> 12051466

Pain in multiple sclerosis: a biopsychosocial perspective.

Robert D Kerns1, Marilyn Kassirer, John Otis.   

Abstract

Clinically significant pain has been found in as many as 65% of persons diagnosed with multiple sclerosis (MS). Acute pain conditions include trigeminal neuralgia, painful optic neuritis, and Lhermitte's syndrome. Chronic pain conditions such as dysesthesias in the limbs, joint pain, and other musculoskeletal or mechanical pain problems develop as a function of spasticity and deconditioning associated with MS. These painful conditions may respond to pharmacological, surgical, rehabilitation, and psychological interventions. However, unresolved pain, associated disability, and affective distress are common. In addition, efforts to manage MS and its associated symptoms, for example, may inadvertently cause osteoporosis and headache or other symptoms that may exacerbate pain and pain-related disability. Conversely, efforts to manage pain may have negative effects on the symptoms of MS (e.g., increased fatigue). A multidimensional approach to assessment and management that is guided by a comprehensive biopsychosocial model is recommended. Such an approach needs to consider the exacerbating nature of MS, MS-related pain, and interventions aimed at their management. Suggestions for future research on MS-related pain conclude the article.

Entities:  

Mesh:

Year:  2002        PMID: 12051466

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  12 in total

Review 1.  Psychosocial factors and adjustment to chronic pain in persons with physical disabilities: a systematic review.

Authors:  Mark P Jensen; Michael R Moore; Tamara B Bockow; Dawn M Ehde; Joyce M Engel
Journal:  Arch Phys Med Rehabil       Date:  2011-01       Impact factor: 3.966

Review 2.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

3.  Effect of a Single Bout of Intermittent versus Continuous Walking on Perceptions of Fatigue in People with Multiple Sclerosis.

Authors:  Herb Karpatkin; Adam Rzetelny
Journal:  Int J MS Care       Date:  2012

4.  Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training.

Authors:  Georgina Sutherland; Mark B Andersen; Tony Morris
Journal:  J Behav Med       Date:  2005-06

5.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

6.  Validity of an observation method for assessing pain behavior in individuals with multiple sclerosis.

Authors:  Karon F Cook; Toni S Roddey; Alyssa M Bamer; Dagmar Amtmann; Francis J Keefe
Journal:  J Pain Symptom Manage       Date:  2012-11-15       Impact factor: 3.612

7.  Pain acts through fatigue to affect participation in individuals with multiple sclerosis.

Authors:  Shahnaz Shahrbanian; Pierre Duquette; Sara Ahmed; Nancy E Mayo
Journal:  Qual Life Res       Date:  2015-08-09       Impact factor: 4.147

8.  The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis.

Authors:  Shahla Najafi Doulatabad; Khirollah Nooreyan; Ardavan Najafi Doulatabad; Zinat Mohebbi Noubandegani
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

9.  Cognitive Behavioral Therapy for the Management of Multiple Sclerosis-Related Pain: A Randomized Clinical Trial.

Authors:  Elizabeth S Gromisch; Robert D Kerns; Rebecca Czlapinski; Beth Beenken; John Otis; Albert C Lo; John Beauvais
Journal:  Int J MS Care       Date:  2020 Jan-Feb

10.  Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model.

Authors:  Dominik Michalski; Stefanie Liebig; Eva Thomae; Andreas Hinz; Florian Then Bergh
Journal:  J Pain Res       Date:  2011-08-02       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.